Hypothesis: An important role for R-verapamil in pharmacoresistant epilepsy

Bioscience Hypotheses

Volumn 2, Issue 1, 2009, Pages 52-53

  Hassanzadeh, K ^a   Ghavimi, H ^a  

^a UNIVERSITY OF TABRIZ   (Iran)

Author keywords

P glycoproteins; Pharmacoresistant epilepsy; R verapamil

Indexed keywords

ANTICONVULSIVE AGENT; DOXORUBICIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; VERAPAMIL;

ARTICLE; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; COMBINATION CHEMOTHERAPY; DRUG BRAIN LEVEL; DRUG PENETRATION; DRUG POTENCY; DRUG POTENTIATION; DRUG RESPONSE; DRUG SAFETY; DRUG TRANSPORT; EPILEPSY; HUMAN; MONOTHERAPY; PROTEIN EXPRESSION; THERAPY RESISTANCE;

EID: 58149187860     PISSN: 17562392     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bihy.2008.10.006     Document Type: Article

References (8)

1. Weiss J., Kerpen C.J., Lindenmaier H., Dormann S.M.G., and Haefeli W.E. Interaction of antiepileptic drugs with human P-glycoprotein in vitro. J Pharmacol Exp Ther 307 (2003) 262-267
2. Wolfgang L., and Heidrun P. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Pharmacol Exp Ther 301 (2002) 7-14
3. Varma M.V.S., Ashokra Y., Dey C.S., and Panchagnula R. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol Res 48 (2003) 347-359
4. Potschka H., Baltes S., and Löscher W. Inhibition of multidrug transporters by verapamil or probenecid does not alter blood-brain barrier penetration of levetiracetam in rats. Epilepsy Res 58 (2004) 85-91
5. Kamimoto Y., Gatmaitan Z., Hsu J., and Arias I.M. The function of Gp170, the multidrug resistance gene product, in rat liver canalicular membrane vesicles. J Biol Chem 264 (1989) 11693-11698
6. Ahmed J.H., Godden J., Meredith P.A., and Eliott H.L. R-verapamil: pharmacokinetics and effects on PR interval, blood pressure and heart rate. Br J Clin Pharmacol 36 (1993) 93-98
7. Perrotton T., Trompier D., Chang X.B., Di Pietro A., and Baubichon-Cortay H. R- and S-verapamil differentially modulate the multidrug resistance protein MRP1. J Biol Chem 282 (2007) 31542-31548
8. Tolcher A.W., Cowan K.H., Solomon D., Ognibene F., Goldspiel B., Chang R., et al. Phase I crossover study of paclitaxel with R-verapamil in patients with metastatic breast cancer. J Clin Oncol 14 (1996) 1173-1184